Browse more Reports on Infectious Diseases Therapeutics at
http://www.rnrmarketresearch.com/reports/life-sciences/pharmace...
This report provides comprehensive information on the therapeutic development
for Nasopharyngitis (Common Cold), complete ...
© http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com
+1 888 391 5441
Nasopharyngitis (Common Cold) - Pipeline...
© http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com
+1 888 391 5441
Scope For Nasopharyngitis (Common Cold) ...
© http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com
+1 888 391 5441
Reasons to Buy:
• Provides strategically...
For more details contact Mr. Ritesh Tiwari : sales@rnrmarketresearch.com / +18883915441
RnRMarkertResearch
RnRMarketResear...
of 6

Nasopharyngitis Common Cold Pipeline Companies and Drugs Review H2 2015

This report provides comprehensive information on the therapeutic development for Nasopharyngitis (Common Cold), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Nasopharyngitis (Common Cold) and special features on late-stage and discontinued projects
Published on: Mar 3, 2016
Published in: Health & Medicine      
Source: www.slideshare.net


Transcripts - Nasopharyngitis Common Cold Pipeline Companies and Drugs Review H2 2015

  • 1. Browse more Reports on Infectious Diseases Therapeutics at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/infectious- diseases-therapeutics . Nasopharyngitis (Common Cold) - Pipeline Review, H2 2015 By RnRMarketResearch.com © http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441 Publisher Name : Global Markets Direct Date: 29-Jul-2015 No. of pages: 47 Single User License: US $2000
  • 2. This report provides comprehensive information on the therapeutic development for Nasopharyngitis (Common Cold), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Nasopharyngitis (Common Cold) and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Nasopharyngitis (Common Cold) - Pipeline Review, H2 2015 © http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
  • 3. © http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441 Nasopharyngitis (Common Cold) - Pipeline Review, H2 2015 Companies Discussed/Mentioned in this Research : Charleston Laboratories, Inc., Cocrystal Pharma, Inc., Neos Therapeutics, Inc., Orbis Biosciences, Inc. and Vernalis Plc Drugs Profile Discussed in this Research : (chlorpheniramine maleate + codeine), Antibody to Target TRIM-21 for Gastrointestinal and Ear Nose Throat Disorders, CCP-05, CCP-06, CCP-07, CCP- 08, CLAT-313, guaifenesin ER, Small Molecule for Cough and Cold, Small Molecule to Inhibit MAPK13 for Asthma and Cold and Small Molecules to Inhibit RNA Dependent RNA Polymerase for Common Cold
  • 4. © http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441 Scope For Nasopharyngitis (Common Cold) - Pipeline Review, H2 2015 • The report provides a snapshot of the global therapeutic landscape of Nasopharyngitis (Common Cold) • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities • The report reviews key players involved in the therapeutics development for Nasopharyngitis (Common Cold) and enlists all their major and minor projects • The report summarizes all the dormant and discontinued pipeline projects • A review of the Nasopharyngitis (Common Cold) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources • Pipeline products coverage based on various stages of development ranging from pre- registration till discovery and undisclosed stages • A detailed assessment of monotherapy and combination therapy pipeline projects Nasopharyngitis (Common Cold) - Pipeline Review, H2 2015
  • 5. © http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441 Reasons to Buy: • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage • Develop strategic initiatives by understanding the focus areas of leading companies • Identify and understand important and diverse types of therapeutics under development for Nasopharyngitis (Common Cold) • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline • Devise corrective measures for pipeline projects by understanding Nasopharyngitis (Common Cold) pipeline depth and focus of Indication therapeutics • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope Nasopharyngitis (Common Cold) - Pipeline Review, H2 2015
  • 6. For more details contact Mr. Ritesh Tiwari : sales@rnrmarketresearch.com / +18883915441 RnRMarkertResearch RnRMarketResearch.com, an online repository of market research reports, offers in-depth analysis of over 5000 market segments. RnR Market Research library has syndicated reports by leading market research publishers across the globe. © http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441 Nasopharyngitis (Common Cold) - Pipeline Review, H2 2015

Related Documents